Scaling Up: High-Throughput ADME Toxicology Testing via Bioprinting
In the highly competitive pharmaceutical industry, speed is just as important as accuracy. The ability to rapidly screen thousands of drug candidates to identify viable therapeutics is the lifeblood of modern drug discovery. Historically, the complexity of creating 3D tissue models made them too slow and labor-intensive for mass screening. However, recent advancements in the 3D bioprinting...
0 Commentaires 0 Parts 9 Vue 0 Aperçu